The FINANCIAL -- UCB SA/NV ("UCB" or the "Company") announces on October 23 that it will offer a minimum of EUR 150 million[1] bonds (the "Bonds") in the form of a retail public offering in Belgium and Luxembourg.

The FINANCIAL -- Exelixis, Inc. (Nasdaq:EXEL) and Bristol-Myers Squibb Company (NYSE:BMY) on October 23 reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.

The FINANCIAL -- GlaxoSmithKline (GSK) on October 23 announced that, to date, more than 150,000 people have received GSK's pandemic H1N1 vaccine, Pandemrix, as part of Government initiated vaccination programmes across Europe which commenced last week.

The FINANCIAL -- Zogenix, Inc. (“Zogenix”), a privately held pharmaceutical company, and Astellas Pharma US, Inc. (“Astellas”) announced that positive results from two clinical studies of new SUMAVEL DosePro (sumatriptan injection) needle-free delivery system will be published in the November 2009 issue of Headache.

The FINANCIAL -- Takeda Pharmaceutical Company Limited (Osaka, Japan, “Takeda”) announced on October 23 that it has received the Good Design Award 2009[1] from the Japan Industrial Design Promotion Organization for the blister card packaging for Benet 17.5 mg tablets, which is indicated for the treatment of osteoporosis.